Fresenius Medical Care AGFMCQF 72 Days Payable is 23.08 as of Mar. 2026, which is 5% below its 10-year median of 24.21. GuruFocus rates FMCQF with a GF Score™ of 72/100 and a GF Value™ of $45.67 (Fairly Valued). The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks worse than 83.17% on this metric.
The historical rank and industry rank for Fresenius Medical Care AG's Days Payable or its related term are showing as below:
FMCQF'
s Days Payable Range Over the Past 10 Years
Min: 21.39 Med: 24.21 Max: 25.89
Current: 21.39
During the past 13 years, Fresenius Medical Care AG's highest Days Payable was 25.89. The lowest was 21.39. And the median was 24.21.
FMCQF's Days Payable is ranked worse than 83.17% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs FMCQF: 21.39
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's Days Payable falls into.
Fresenius Medical Care AG Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Fresenius Medical Care AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG (FMCQF) has a Days Payable of 23.08 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fresenius Medical Care AG and its competitors. This is near median its historical median of 24.21. Over the past decade, Fresenius Medical Care AG's Days Payable has ranged from 21.39 to 25.89. According to the industry distribution chart, Fresenius Medical Care AG ranks #504 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 83.2%.
Is Fresenius Medical Care AG's Days Payable too high?
Fresenius Medical Care AG's current Days Payable of 23.08 is near median its 10-year median of 24.21. Over the past 10 years, this metric has ranged from a low of 21.39 to a high of 25.89. The Healthcare Providers & Services industry median Days Payable is 58.21. Fresenius Medical Care AG's value of 23.08 is 60.3% below this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #504 out of 606 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Fresenius Medical Care AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #504 out of 606 companies for Days Payable. This places Fresenius Medical Care AG in the lower half of its industry. The industry median Days Payable is 58.21. Fresenius Medical Care AG's value of 23.08 is 60.3% below this benchmark. Historically, Fresenius Medical Care AG's own Days Payable has ranged from 21.39 to 25.89 over the past decade. While the company's 10-year median is 24.21 vs. the industry median of 58.21, Fresenius Medical Care AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current Days Payable of 23.08 is 60.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current Days Payable is 23.08, which is near median its own 10-year median of 24.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMCQF) is currently considered Fairly Valued. The stock's GF Value™ is $45.67, compared to a current price of $45.17 — trading 1.1% below its estimated fair value. The current Days Payable is 23.08, which is near median its 10-year median of 24.21 and 60.3% below the Healthcare Providers & Services industry median of 58.21. Fresenius Medical Care AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Fresenius Medical Care AG (FMCQF), the current Days Payable is 23.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (FMCQF) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of $45.17 is trading 1.1% below its estimated GF Value™ of $45.67.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for FMCQF:
Days Payable: 23.08 (near median its 10-year median of 24.21)
GF Value™: $45.67 vs. price of $45.17 (1.1% below fair value)
Industry Position: 60.3% below the Healthcare Providers & Services median (#504 of 606)
No single metric tells the full story. See the FMCQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
72GF Score
Get the complete analysis for FMCQF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FMCQF has been successfully added to your 
